ENG/中
老虎证券
行情
产品介绍
Cash Boost账户
新加坡股
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登录
立即注册
Toggle
美股
详情
本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务
Insight Molecular Diagnostics Inc.
3.03
+0.1700
5.94%
成交量:
8.76万
成交额:
26.19万
市值:
8,665.58万
市盈率:
-0.91
高:
3.07
开:
2.97
低:
2.85
收:
2.86
数据加载中...
总览
公司
新闻
公告
公司资料
公司名字:
Insight Molecular Diagnostics Inc.
交易所:
NASDAQ
成立时间:
2009
员工人数:
48
公司地址:
2 International Plaza Dr.,Suite 510,Nashville,Tennessee,United States
官网:
http://www.oncocyte.com
邮编:
37217
电话:
949 409 7600
传真:
- -
简介:
Insight Molecular Diagnostics Inc.于2009年在加利福尼亚州注册成立,是Bio Time的一家拥有多数股权的子公司。该公司是一家精准诊断公司,专注于开发和商业化三个领域的专有测试:VitaGraft是一种基于血液的实体器官移植监测测试,DetermaIO是一种评估肿瘤微环境以预测对免疫疗法的反应的基因表达测试,DetermaCNI是一种基于血液的监测工具,用于监测癌症患者的治疗效果。该公司正在继续开发DetermaIO,这是一种具有前景数据的测试,支持其帮助识别可能对检查点抑制剂药物产生反应的患者的潜力。这类新药可调节免疫反应,在包括非小细胞肺癌(NSCLC)、三阴性乳腺癌(TNBC)在内的多种实体瘤类型中显示活性。
董事
名称
职位
Andrew Arno
Chairman of the Board
Joshua Riggs
President and Chief Executive Officer and Director
Louis E. Silverman
Lead Independent Director
Alfred D. Kingsley
Director
Andrew J. Last
Director
Jennifer Levin Carter
Director
John Peter Gutfreund
Director
股东
名称
职位
Joshua Riggs
President and Chief Executive Officer and Director
Anish John
Chief Financial Officer
James Liu
Controller and Principal Accounting Officer
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/hans/stock/IMDX/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IMDX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMDX\",,,,,undefined,":{"symbol":"IMDX","market":"US","secType":"STK","nameCN":"Insight Molecular Diagnostics Inc.","latestPrice":3.03,"timestamp":1753128000000,"preClose":2.86,"halted":0,"volume":87578,"delay":0,"floatShares":7755045,"shares":28599285,"eps":-3.342915,"marketStatus":"盘前交易","change":0.17,"latestTime":"07-22 05:59:57 EDT","open":2.97,"high":3.07,"low":2.85,"amount":261890.8849,"amplitude":0.076923,"askPrice":3.36,"askSize":100,"bidPrice":1.83,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-3.342915,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753191000000},"marketStatusCode":1,"adr":0,"exchange":"NASDAQ","adjPreClose":3.03,"dividendRate":0.00033,"postHourTrading":{"tag":"盘后","latestPrice":3.03,"preClose":3.03,"latestTime":"16:06 EDT","volume":2,"amount":5.83,"timestamp":1753128407837},"volumeRatio":2.6790434036361686},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IMDX\",,,,,undefined,":{"symbol":"IMDX","floatShares":7755045,"roa":"-22.17%","roe":"-428.96%","lyrEps":-4.661158,"volumeRatio":2.6790434036361686,"shares":28599285,"dividePrice":0.001,"high":3.07,"amplitude":0.076923,"preClose":2.86,"low":2.85,"week52Low":1.922,"pbRate":"8.48","psRate":"22.55","week52High":4.75,"institutionHeld":0,"latestPrice":3.03,"eps":-3.342915,"divideRate":0.00033,"volume":87578,"delay":0,"ttmEps":-3.342915,"open":2.97,"prevYearClose":2.38,"prevWeekClose":2.86,"prevMonthClose":3.02,"prevQuarterClose":3.02,"fiveDayClose":2.84,"twentyDayClose":4.24,"sixtyDayClose":2.95},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":78474527,"yearFounded":2009,"employeeNum":48,"address":"2 International Plaza Dr.,Suite 510,Nashville,Tennessee,United States","zipCode":"37217","officePhone":"949 409 7600"},"stockCompanyDetail":{"websiteUrl":"http://www.oncocyte.com","stockEarnings":[{"period":"1week","weight":0.0669},{"period":"1month","weight":-0.2854},{"period":"3month","weight":0.0377},{"period":"6month","weight":0.5459},{"period":"1year","weight":-0.0561},{"period":"ytd","weight":0.2731}],"compareEarnings":[{"period":"1week","weight":0.0063},{"period":"1month","weight":0.058},{"period":"3month","weight":0.1925},{"period":"6month","weight":0.0368},{"period":"1year","weight":0.1453},{"period":"ytd","weight":0.0728}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Insight Molecular Diagnostics Inc.于2009年在加利福尼亚州注册成立,是Bio Time的一家拥有多数股权的子公司。该公司是一家精准诊断公司,专注于开发和商业化三个领域的专有测试:VitaGraft是一种基于血液的实体器官移植监测测试,DetermaIO是一种评估肿瘤微环境以预测对免疫疗法的反应的基因表达测试,DetermaCNI是一种基于血液的监测工具,用于监测癌症患者的治疗效果。该公司正在继续开发DetermaIO,这是一种具有前景数据的测试,支持其帮助识别可能对检查点抑制剂药物产生反应的患者的潜力。这类新药可调节免疫反应,在包括非小细胞肺癌(NSCLC)、三阴性乳腺癌(TNBC)在内的多种实体瘤类型中显示活性。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.314148},{"month":2,"riseRate":0.2,"avgChangeRate":-0.066709},{"month":3,"riseRate":0.8,"avgChangeRate":0.036833},{"month":4,"riseRate":0.5,"avgChangeRate":-0.026133},{"month":5,"riseRate":0.4,"avgChangeRate":-0.004941},{"month":6,"riseRate":0.3,"avgChangeRate":-0.09229},{"month":7,"riseRate":0.3,"avgChangeRate":-0.100339},{"month":8,"riseRate":0.444444,"avgChangeRate":0.016115},{"month":9,"riseRate":0.444444,"avgChangeRate":0.040094},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.127503},{"month":11,"riseRate":0.444444,"avgChangeRate":0.049155},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.032814}],"exchange":"NASDAQ","name":"Insight Molecular Diagnostics Inc.","nameEN":"Insight Molecular Diagnostics Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"IMDX\",market:\"US\",,,undefined,":{"directors":[{"name":"Andrew Arno","position":"Chairman of the Board"},{"name":"Joshua Riggs","position":"President and Chief Executive Officer and Director"},{"name":"Louis E. Silverman","position":"Lead Independent Director"},{"name":"Alfred D. Kingsley","position":"Director"},{"name":"Andrew J. Last","position":"Director"},{"name":"Jennifer Levin Carter","position":"Director"},{"name":"John Peter Gutfreund","position":"Director"}],"executives":[{"name":"Joshua Riggs","position":"President and Chief Executive Officer and Director"},{"name":"Anish John","position":"Chief Financial Officer"},{"name":"James Liu","position":"Controller and Principal Accounting Officer"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IMDX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-05-12","symbol":"IMDX","fiscalQuarterEnding":"2025/03","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1747022400000,"reportTimeType":"post","actualEps":-0.26},{"market":"US","date":"2025-03-24","symbol":"IMDX","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1742788800000,"reportTimeType":"post","actualEps":0.48},{"market":"US","date":"2024-11-12","symbol":"IMDX","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-0.98},{"market":"US","date":"2024-08-08","symbol":"IMDX","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1723089600000,"reportTimeType":"post","actualEps":-0.36},{"market":"US","date":"2024-05-15","symbol":"IMDX","fiscalQuarterEnding":"2024/03","expectedEps":-0.82,"name":null,"time":"盘后","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"post","actualEps":-1.13}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IMDX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IMDX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.5,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1743393600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/IMDX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"IMDX","date":"2025-07-21","current":-1.405274,"percent":0.65,"low":-2.083343,"twenty":-1.638667,"median":-1.459323,"eighty":-1.40036,"high":-1.365916,"avg":-1.520272,"sd":0.171044,"marketCap":81793955},"quantilePoints":[{"date":"2025-06-20","current":-1.55268,"twenty":-1.55268,"median":-1.55268,"eighty":-1.55268,"marketCap":90373740},{"date":"2025-06-27","current":-1.655864,"twenty":-1.798357,"median":-1.675518,"eighty":-1.638667,"marketCap":96379590},{"date":"2025-07-03","current":-1.40036,"twenty":-1.71581,"median":-1.6055,"eighty":-1.491752,"marketCap":81507962},{"date":"2025-07-11","current":-1.420014,"twenty":-1.663726,"median":-1.493717,"eighty":-1.427876,"marketCap":82651933},{"date":"2025-07-18","current":-1.390533,"twenty":-1.642106,"median":-1.471607,"eighty":-1.399377,"marketCap":80935976},{"date":"2025-07-21","current":-1.405274,"twenty":-1.638667,"median":-1.459323,"eighty":-1.40036,"marketCap":81793955}],"updateTime":1753178397839}}}